The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Specific Drug Delivery to Cancer Cells with Double-Imprinted Nanoparticles against Epidermal Growth Factor Receptor
Open accessAbstract
Epidermal growth factor receptor (EGFR), a tyrosine kinase receptor, is over-expressed in many tumors, including almost half of triple-negative breast cancers. The latter belong to a very-aggressive and drug-resistant form of malignancy. Although humanized anti-EGFR antibodies can work efficiently against these cancers both as monotherapy and in combination with genotoxic drugs, instability and high production costs are some of their known drawbacks in clinical use. In addition, the development of antibodies to target membrane proteins is a very challenging task. Accordingly, the main focus of the present work is the design of supramolecular agents for the targeting of membrane proteins in cancer cells and, hence, more-specific drug delivery. These were produced using a novel double-imprinting approach based on the solid-phase method for preparation of molecularly imprinted polymer nanoparticles (nanoMIPs), which were loaded with doxorubicin and targeted toward a linear epitope of EGFR. Additionally, upon binding, doxorubicin-loaded anti-EGFR nanoMIPs elicited cytotoxicity and apoptosis only in those cells that over-expressed EGFR. Thus, this approach can provide a plausible alternative to conventional antibodies and sets up a new paradigm for the therapeutic application of this class of materials against clinically relevant targets. Furthermore, nanoMIPs can promote the development of cell imaging tools against difficult targets such as membrane proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cho, H.-S., Dong, Z., Pauletti, G. M., Zhang, J., Xu, H., Gu, H., Wang, L., Ewing, R. C., Huth, C., Wang, F., et al. (2010) · ACS Nano · doi:10.1021/nn101000e · Cited by 265
Cited by
Molecular Imprinting: Green Perspectives and Strategies
Arabi, M., Ostovan, A., Li, J., Wang, X., Zhang, Z., Choo, J., & Chen, L. (2021) · Advanced Materials · doi:10.1002/adma.202100543 · Cited by 780
Molecularly Imprinted Polymers: Antibody Mimics for Bioimaging and Therapy
Haupt, K., Medina Rangel, P. X., & Bui, B. T. S. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00428 · Cited by 561
Strategies of molecular imprinting-based solid-phase extraction prior to chromatographic analysis
Arabi, M., Ostovan, A., Bagheri, A. R., Guo, X., Wang, L., Li, J., Wang, X., Li, B., & Chen, L. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.115923 · Cited by 463
Greenificated Molecularly Imprinted Materials for Advanced Applications
Ostovan, A., Arabi, M., Wang, Y., Li, J., Li, B., Wang, X., & Chen, L. (2022) · Advanced Materials · doi:10.1002/adma.202203154 · Cited by 442
Molecularly Imprinted Nanoparticles for Biomedical Applications
Zhang, H. (2020) · Advanced Materials · doi:10.1002/adma.201806328 · Cited by 341
Metadata
- Authors
- Canfarotta, F., Lezina, L., Guerreiro, A., Czulak, J., Petukhov, A., Daks, A., Smolinska-Kempisty, K., Poma, A., Piletsky, S., & Barlev, N. A.
- Venue
- Nano Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-07-03
- Volume
- 18
- Issue
- 8
- Pages
- 4641-4646
- ISSN
- 1530-6984 (ISSN-L)
- 1530-6992
- OpenAlex
- W2811278819
- Cited by
- 175
- References
- 1
- FWCI
- 6.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Specific Drug Delivery to Cancer Cells with Double-Imprinted Nanoparticles against Epidermal Growth Factor Receptor. https://app.cochat.ai/papers/10.1021/acs.nanolett.7b03206
- The paper
- Canfarotta, F., Lezina, L., Guerreiro, A., Czulak, J., Petukhov, A., Daks, A., Smolinska-Kempisty, K., Poma, A., Piletsky, S., & Barlev, N. A. (2018). Specific Drug Delivery to Cancer Cells with Double-Imprinted Nanoparticles against Epidermal Growth Factor Receptor. Nano Letters. https://doi.org/10.1021/acs.nanolett.7b03206
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.